Here is a fact that still surprises people: there is no medicine approved specifically to treat the disease of pancreatitis. Not the acute kind, not the recurrent kind, not the chronic kind. We manage symptoms, we replace enzymes, we manage pain, but the disease itself has no licensed drug aimed straight at it. That is a hard thing to sit with when you are living with it.
I am writing this anyway because the pipeline is not empty. There is real work happening, and some of it is genuinely encouraging. You deserve to know it exists, and to know how pain is handled in the meantime.
First, what exists now. Chronic pancreatitis pain is usually managed in steps: simple painkillers first, then medicines aimed at nerve-type pain such as certain antidepressants or anti-seizure drugs, with opioids used cautiously and as late as possible because of dependence and because they can worsen gut function. Beyond medicines, there are procedures, a nerve block called a coeliac plexus block, endoscopic treatments to relieve a blocked or stone-filled pancreatic duct, and surgery for selected cases. The point is that “nothing works” is not the same as “nothing is available.” A good pain plan is layered.
Now the research. The one getting the most attention is proglumide. It is an old drug, originally used for stomach ulcers, being repurposed because it blocks a signal called cholecystokinin (CCK) that appears to drive some pancreatitis pain and inflammation. In an early-phase trial, patients reported significantly less pain after 12 weeks on proglumide compared with their pain before treatment, measured on standard pain scales. It was generally well tolerated, with some nausea and diarrhoea at the higher dose. A larger Phase 2 stage is the next step.
I want to be straight about what that means. Early-phase trials are small. “Significantly less pain in eight people over twelve weeks” is a promising signal, not a finished answer, and plenty of drugs look good early and still do not make it. Treat this as reason for cautious hope, not a treatment you can ask for tomorrow.
Beyond proglumide, the broader effort is worth knowing about. Antioxidant therapy has been studied for chronic pancreatitis pain with mixed results, helpful for some, not a cure. Researchers are testing anti-inflammatory and cell-protective compounds, and in the most advanced surgical research, exploring ways to switch off the damaging part of the pancreas while preserving the insulin-making part. Some of this is still in the lab. Some is reaching people.
Stepan’s Rule: Hope and honesty are not opposites. You can be encouraged by a trial and still hold it loosely until the bigger study lands. And while you wait, push for a proper layered pain plan, that part is available now.
If you want to do more than read, you can look for trials yourself. The National Pancreas Foundation runs a clinical-trial resource centre, Mission:Cure tracks the drug-development pipeline in plain language, and ClinicalTrials.gov lists what is recruiting. Whether a trial is right for you is a conversation for you and your specialist, but knowing they exist puts a little power back in your hands.
This is the kind of news I find genuinely lifting on a bad week, and it is better shared than read alone. Our community keeps an eye on this together, swaps what people find, and talks it through without the hype. If the pipeline gives you hope, come and sit with people who feel the same.
Patient summary of public research, not medical advice. Trial participation is decided with your specialist.